. Effector memory T cells (T EM cells) generally patrol regions outside of LNs and are typically thought of as terminally differentiated peripheral surveyors poised for rapid expression of effector functions, but not secondary expansion [4] [5] [6] . Both T CM cells and T EM cells recirculate, meaning they can be found in blood. T RM cells 7 , a third major population of memory T cells, are parked in tissues, where they accelerate clearance of local reinfections, and thus are absent from blood 7, 8 . Because T RM cells share properties with effector T cells and T EM cells, potentially including the expression of CD69 and granzyme B and the absence of LN homing receptors such as CD62L, the prevailing view is that T RM cells are also terminally differentiated, and thus are not responsible for expansion of their own population or boosting of local nonlymphoid tissue secondary memory T cell populations after reinfection. Rather, boosting of tissue memory is thought to require antigen trafficking to downstream lymphoid organs and proliferation and differentiation by the more 'stem-celllike' T CM cells. Indeed, when T RM cells are restimulated outside of nonlymphoid tissues, expansion is poor compared with that of naive T cell or T CM cell populations, which suggests that T cell intrinsic differences impair proliferation potential [9] [10] [11] . However, T RM cells are difficult to study ex vivo because of their poor survival after being removed from tissues [12] [13] [14] . T RM cells can trigger a tissue-wide state of pathogen resistance and immune stimulation, and precipitate the recruitment of recirculating lymphocytes to sites of T RM cell reactivation 15, 16 . However, the fate of recruited cells is unclear. Moreover, formal descriptions of the relationship between CD8 + T cell magnitude, location and differentiation state and the efficiency of pathogen detection and clearance are in their infancy. Indeed, we lack in vivo data for mucosal T RM cell motility, which is intrinsically related to the scanning rate of potential target cells. Intravascular T RM cells that patrol liver sinusoids are motile, but it is unclear whether this is true of the numerous T RM cells that survey connective tissues and parenchymal barriers 13 . Indeed, T RM cell motility in skin epidermis is quite low (~2 μ m min -1 ), in contrast to that of T CM cells surveilling LNs (~10 μ m min -1 ) 15, [17] [18] [19] . This suggests that resident populations of memory T cells not only do not migrate between tissues, but also may be relatively stationary within stromal or parenchymal tissues.
To address T RM cell immunosurveillance in the mucosa, we developed an intravital two-photon microscopy model to image mouse uterus after acute lymphocytic choriomeningitis virus (LCMV) infection and combined it with depletion strategies, parabiosis and dual-challenge models to test the relative contributions of T RM cells to secondary population expansion after local anamnestic antigen exposure. We found that compared with circulating memory T cells, T RM cells in both the female reproductive tract and the skin have the potential to dominate local recall responses and contribute most substantially to boosting of the secondary T RM cell population. These data indicate that T RM cells have the capacity to autonomously regulate the expansion of local immunosurveillance independently of T CM cells or proliferation in lymphoid tissue.
Results
T cell motility accelerates after antigen clearance in the female reproductive tract. To establish a model for observing dynamic T cell behavior in the female reproductive tract (FRT) in living mice, we transferred GFP +
CD8
+ P14 T cell receptor-transgenic (P14) T cells, which are specific for the immunodominant gp33 epitope of LCMV, into naive C57BL/6 mice and then infected the recipients with 2 × 10 5 plaque-forming units of LCMV Armstrong intraperitoneally (i.p.). This resulted in LCMV infection of the FRT (Fig. 1a) , as well as establishment of GFP + P14 T RM cells in all three layers of the uterine horn [20] [21] [22] ( Supplementary Fig. 1a ,b) in the recipient mice (hereinafter referred to as GFP + P14 immune chimeras). Mice are multiparous and have relatively long uterine horns, which could be sufficiently exteriorized to be imaged under laser-scanning intravital two-photon microscopy (IV-2PM; Methods) while remaining intact within the mouse. Using this approach, we visualized the motility of LCMV-specific GFP + P14 T RM cells within the uterine mucosa at different stages of LCMV infection. We focused all live imaging on the most superficial 200 μ m, which was the optimal depth for use with the instrumentation and tissue properties in this experiment. Thus, our analyses were restricted to the perimetrium and myometrium, and did not include the endometrium or luminal epithelium.
At day 4.5 after LCMV infection, GFP + P14 T cell motility was approximately 6 μ m min -1 , with some GFP + P14 T cells arrested (Fig. 1b-d and Supplementary Video 1). Motility increased to ~10 μ m min -1 by day 8 after infection, which coincided with the time of observable antigen clearance after LCMV Armstrong infection in mice ( Fig. 1a and Supplementary Video 2). At day 30 after LCMV infection, at which time T cells in the FRT are almost exclusively T RM cells 12, 21 , GFP + P14 T cell motility remained high at ~10 μ m min -1 (Supplementary Video 3). Antigen clearance was also accompanied by an increase in the motility coefficient, expressed as the rate of GFP + P14 T cell displacement from the starting position (Fig. 1c) . These data suggest that CD8 + T RM cell motility in the stroma of the FRT is much faster than that reported in skin epidermis (2 μ m min -1 ) 17 . The motility of GFP + OT-I memory T cells, which recognize the ovalbumin (OVA)-derived peptide SIINFEKL, established in the FRT 60 d after infection with either vesicular stomatitis virus (VSV) or vaccinia virus (VV) expressing OVA (VSV-OVA or VV-OVA, respectively) was also ~10 μ m min -1 (Fig. 1e) . The discrepancy in motility that we observed between the FRT and what has been reported for skin epidermis, which comprises compacted layers of flattened cells, could be due to the difference in tissue architecture. We found that the motility of GFP + P14 T cells was lower (~6 μ m min -1 ) in the perimetrium (the outer serosal lining of the uterus) and the subjacent thin layer of dense connective tissue than in the myometrium (the muscular layer of the uterus; ~10 μ m min -1 ) ( Supplementary Fig. 2 ). In fact, the average speed of GFP + P14 T cells migrating in less collagen-rich areas (tracks > 2 μ m away from second harmonic generation (SHG) signals) was significantly faster than that of cells close to collagen-dense regions ( < 2 μ m from SHG signals; Fig. 1f,g ). In summary, both antigen and location have a role in CD8 + T cell migration within the uterine stroma.
Local reactivation results in motility arrest of T RM cells. Previous studies indicated that > 99% of LCMV-Armstrong-specific P14 CD8 + T cells within the FRT are resident at any time point 1-8 months after LCMV infection, 60-75% of T RM cells in the FRT express CD69, and only a minority express CD103 12 . To test whether T RM cell motility is affected by local antigen detection, which could influence subsequent immunosurveillance rates, we used mice that had received adoptively transferred GFP + P14 T cells and been infected with LCMV Armstrong as described above, and we deposited LCMV-gp33 peptide into the lumen of the cervix (trans-cervical delivery) in these mice 60 d after primary LCMV infection. Corresponding with T RM cell reactivation 16, 21 , we observed changes in dendritic cell morphology and a reduction in the average motility of GFP +
+ P14 T cells from 10.1 μ m min -1 at steady state to 5.3 μ m min -1 within 12 h (Fig. 2a,b and Supplementary Videos 4 and 5). These motility changes were transient, as GFP +
+ P14 T cells resumed their previous migration behavior with respect to both mean track speed and motility coefficient within 48 h after gp33 exposure (Fig. 2b) .
We next tested whether T RM cell motility arrest is dependent on stimulation by cognate antigen or is a result of bystander effects of local peptide exposure and/or neighboring T RM cell activation. To generate mice with traceable T RM cells with discrete antigenic specificities, we adoptively transferred GFP + OT-I T cells into cyan fluorescent protein (CFP)-expressing P14 immune chimeras 30 d after LCMV infection, and then infected the chimeras with VSV-OVA. Thirty days after VSV-OVA infection, we exposed the CFP +
P14-GFP
+ OT-I immune chimeric mice to gp33 peptide locally through trans-cervical rechallenge, and monitored the mean track speeds of CFP + P14 T cells and GFP + CD8 + OT-I T cells simultaneously (Supplementary Video 6). Only the migration of CFP + P14 T cells was reduced at 12 h compared with that of resting OT-I CD8 + memory T cells that did not recognize recall antigen (Fig. 2c,d ), which indicated that T RM cell motility arrest depends on cognateantigen-specific T-cell-receptor-mediated signals, rather than bystander effects.
In situ division in the female reproductive tract. Next, we assessed the dynamics of the response in the FRT after local antigen rechallenge by infecting mice carrying adoptively transferred P14 CD8 + T cells with LCMV Armstrong and then subjecting them to transcervical rechallenge with gp33 60 d after LCMV infection. IV-2PM monitoring of the recall response indicated the accumulation of GFP + P14 T cells in the uterine mucosa 36 and 48 h after gp33 peptide inoculation (Fig. 3a,b) . We observed hundreds of GFP + P14 T cells undergoing in situ division at 36 h after gp33 peptide inoculation, with rare examples as early as 32 h (Fig. 3c and Supplementary Video 7). Consistent with this observation, P14 CD8 + T cells in the FRT were Ki67 + 48 h after local rechallenge, which indicates that they were undergoing proliferation (Fig. 3d,f and Supplementary  Fig. 1c,d ). The mice were also i.p. pulsed with 5-bromo-2′ -deoxyuridine (BrdU) 2 h before they were killed. By 2 h after BrdU treatment, ~25% of P14 CD8 + T cells had incorporated BrdU (Fig. 3d) , which indicated that they were undergoing active DNA synthesis and thus confirmed that they were proliferating.
Transgenic fluorophore-expressing CD8 + T cells are necessary for IV-2PM visualization of antigen-specific responses. To determine whether the division of GFP + P14 T cells was an artifact of adoptive transfer, we immunized C57BL/6 J (B6; 'wild-type') mice with LCMV, rechallenged the mice with gp33 peptide trans-cervically 90 d after infection, and measured Ki67 expression and BrdU incorporation in endogenous LCMV-specific CD8 + T cells detected with H-2D b / gp33 MHC I tetramers ( Supplementary Fig. 3 
CD8
+ OT-I T cells into naive B6 recipients and then immunized them with VSV-OVA. Ninety days later, we challenged the mice trans-cervically with VV-OVA or VV expressing gp33 epitope (VV-gp33). CD45.1
+

CD8
+ OT-I T cells became Ki67 + and/or BrdU + in response to cognate-antigenbearing viral rechallenge, which indicates that live replicating virus induced division by antigen-specific CD8 + T cells within the FRT (Fig. 3e,g ). Lastly, we assessed the relationship between motility and division. Two months after primary LCMV infection, we challenged GFP + P14 immune chimeras with LCMV-gp33 peptide trans-cervically, and 36 h after gp33 recall we used intravital microscopy to monitor the motility of GFP + P14 T cells undergoing active division compared with that of GFP + P14 T cells that were not dividing in a 15-min period. Dividing GFP + P14 T cells underwent a transient reduction in motility, then regained rapid motility after cytokinesis was completed (Fig. 3h,i and Supplementary Video 7). In summary, these data indicate that antigen-specific memory T cells in the FRT undergo pausing and cytokinesis after local antigen rechallenge. T RM cells divide in the female reproductive tract after reactivation. We next investigated whether T RM cells in the FRT undergo division in situ, or whether antigen rechallenge induces the division of only antigen-specific T cells newly recruited from the blood, such as T CM cells. Using mice that had previously received adoptively transferred GFP + P14 T cells and been infected with LCMV Armstrong as described above, we administered anti-CD90.1 titrated to induce depletion of blood P14 CD8 + T cells, but insufficient to deplete P14 CD8 + T cells confined within the FRT. A single dose of anti-CD90.1 caused P14 CD8 + T cells to be almost completely eliminated from blood, LNs and spleen while remaining abundant in the FRT (Fig. 4a) . We additionally blocked the migration of circulating P14 CD8 + T cells into the FRT by injecting anti-VCAM-1 and anti-CD49d 24 h before and 24 h after trans-cervical challenge with gp33 16 . For proliferation monitoring, we administered BrdU i.p. 2 h before we collected P14 CD8 + T cells from the FRT. We observed that 24 and 36 h after gp33 challenge, P14 CD8 + T cells in the FRT of mice treated with anti-CD90.1, anti-VCAM-1 and anti-CD49d showed equivalent BrdU incorporation and Ki67 upregulation compared with T cells in challenged mice that did not receive antibodies (Fig. 4b,c) . In addition, intravital microscopy showed GFP + P14 T cell proliferation in situ in GFP + P14 immune chimeras treated with these antibodies (Supplementary Video 8).
These results indicate that P14 CD8
+ T RM cells rapidly initiate in situ proliferation in the FRT mucosa after anamnestic challenge.
It was previously shown that help from CD4
+ T cells is required to promote CD8 + T cell migration to the mouse FRT and to establish local CD8
+ T cell memory after infection with a thymidinekinase-deficient strain of herpes simplex virus (HSV) type 2 23 .
However, CD4
+ T cell help is dispensable for the establishment of skin CD8
+ T RM cells after exposure to VV 24 . Moreover, CD4 + T cell help has been reported to be important for priming memory CD8 + T cells that retain proliferative potential, although this has not been addressed for T RM cells 25, 26 . Thus we addressed whether the establishment of T RM cells in the FRT requires help from CD4 + T cells after infection with LCMV, by transferring naive P14 CD8 + T cells into MHC-II-deficient recipients and then infecting them with LCMV Armstrong 1 d after cell transfer. We collected P14 CD8 + T cells from the FRT of MHC-II-deficient mice and from wild-type B6 mice 40 d after infection, and found that the cell numbers were similar in both groups of mice ( Supplementary Fig. 4 ). We observed similar results at 7 d after LCMV infection and in Cd4 −/− mice (data not shown and Supplementary Fig. 4 ). Next, we depleted the circulating P14 CD8
+ T cells with anti-CD90.1 (administered i.p. 96 h before rechallenge) and blocked de novo migration into the FRT with anti-VCAM-1 and anti-CD49d (administered i.p. 1 d before the rechallenge) in wild-type and MHC-II-deficient P14 immune chimeras, and then rechallenged the mice with gp33 trans-cervically. Upregulation of Ki67 by CD90.1
+ P14 T cells was equivalent (~40%) in wild-type and MHC-II-deficient mice ( Fig. 4d) , which suggests that CD90.1 + CD8 + P14 T cells did not require CD4
+ T cell help during either priming or reactivation to initiate entry into the cell cycle. We also tested the requirement for CD11c + cells, which include dendritic cells, for T RM cell reactivation. We irradiated B6 mice and then transplanted bone marrow from CD11c-DTR mice, in which CD11c
+ cells express the diphtheria toxin (DT) receptor. Two months later, we delivered adoptively transferred CD90.1 + CD8 + P14 T cells into the CD11c-DTR chimeric mice and infected them with LCMV Armstrong. Sixty days after LCMV infection, we began treating the mice with DT, with administration every 2 d starting at 48 h before trans-cervical rechallenge with gp33, which resulted in depletion of ~90% of CD11c + cells in the FRT (Supplementary Fig. 4d ). Twenty-four hours after gp33 challenge, ~35% of P14 CD8
+ T cells upregulated Ki67 at similar levels in DT-treated and untreated control mice (Fig. 4e) . These results indicate that bona fide T RM cells were triggered to undergo proliferation in situ after mucosal tissue rechallenge, and that this process did not depend on CD4 + T cell help and was probably independent of CD11c + host cells.
Recruited circulating bystanders convert to T RM cells. T RM cell reactivation in the mucosa induces rapid upregulation of inflammatory homing molecules, which results in local recruitment of circulating memory T cells in a chemokine-and integrin-dependent process 21 . However, the long-term fate of these newly recruited bystander CD8 + T cells is unknown. To address this issue, we isolated memory OT-I CD8 + T cells from the spleen and LNs of mice that had been infected with VSV-OVA at least 60 d prior and transferred them i.v. into mice that had received adoptively transferred P14 CD8
+ T cells and been infected with LCMV Armstrong at least (Fig. 5a) . A substantive fraction of the CD45.1 + CD8 + OT-I T cells were CD69 + , although 60% were CD69 -, and very few expressed CD103 (Fig. 5b,c) . Despite this phenotypic heterogeneity, we assessed whether the recruited OT-I CD8 + T cells were resident by transferring circulating memory CD45.1 + CD8 + OT-I T cells into CD90.1 + P14 immune chimeric mice and then challenging the mice with gp33 peptide trans-cervically to recruit the OT-I CD8 + T cells to the FRT. Forty days after gp33 challenge, we surgically joined these mice with naive B6 mice (Fig. 5d) . At 35 d after parabiosis, we could not detect any CD45.1 + CD8 + OT-I T cells in the FRTs of the naive parabiotic partners (Fig. 5e) , which indicated that almost all bystander memory OT-I T cells retained were resident. These data suggest that induction of the T RM cell program within the FRT does not absolutely require local cognate antigen recognition, that recirculating memory T cells retain the developmental potential to differentiate into T RM cells, and that periodic reinfection events may induce bystander memory T cell redistribution out of circulation and into mucosal tissues.
T RM cell proliferation dominates expansion of local secondary memory. Local exposure to anamnestic antigen resulted in rapid and profound population expansion of mucosal antigen-specific T cells (Fig. 3) . This recall response could have been dominated by non-T RM cells (for example, T CM cells that were reactivated in the draining LN or were newly recruited to the FRT) or in situ expansion of preformed T RM cells. To distinguish among these possibilities, we adoptively transferred naive CD8 + T cells from CD45.1 + P14 mice or CD90.1 + P14 mice into CD45.2 + CD90.2 + C57BL/6 recipient mice and infected those recipients with LCMV the following day. Sixty days after LCMV infection, we carried out para- biotic surgery to join CD45.1 + P14 mice and CD90.1 + P14 immune chimeric mice, and we allowed 14-30 d after surgery to induce equilibration of circulating P14 CD8 + T cells before proceeding to trans-cervical challenge with gp33 in both mice of the parabiotic pair ( Supplementary Fig. 5 ). As shown by both flow cytometry and quantitative immunofluorescence microscopy (QIM), the ratios of CD45.1 + CD8 + P14 T cells to CD90.1 + CD8 + P14 T cells were similar in the spleens of both mice in the parabiotic pair 2 d after gp33 challenge (Fig. 6a,b) . In contrast, in the FRT compartment, host P14 CD8 + T cells dominated over parabiotic-partner-derived P14 CD8 + T cells (Fig. 6b,c) , even though the total number of P14 CD8 + T cells in the FRT had increased tenfold (Fig. 6d) , which indicated that 2 d after local rechallenge most of the accumulating antigenspecific T cells were derived from T RM cells. Consistent with this interpretation, at this early time point, most host-derived P14 CD8 + T cells in the FRT expressed markers of T RM cells (particularly CD69), in contrast to parabiont-partner-derived P14 CD8
+ T cells (Fig. 6a) . The disequilibrium between host and donor-derived P14
CD8
+ T cells in the FRT was more pronounced 30 d after local challenge (the host/parabiont-partner-derived P14 CD8 + T cell ratio was ~10:1 at day 2, compared with ~24:1 at day 30) (Fig. 6c,e-g ), which suggests that T RM cells locally expanding during the effector phase of the response had a greater propensity to differentiate into secondary memory T RM cells compared with recirculating memory T cells. We observed an approximately threefold increase in the number of total memory T cells (combined host and parabiontpartner-derived P14 CD8 + T cells) in the FRT 30 d after rechallenge (Fig. 6d) , with the host/parabiont-partner P14 CD8 + T cell ratio highly biased in favor of the host cells (Fig. 6g ). These data demonstrate that at least in this reductionist setting, T RM cells can contribute substantively to secondary effector accumulation and local anamnestic memory.
To extend our analysis to a different rechallenge model and a different anatomic site, we adoptively transferred either CD45. + T cells were resident, we carried out parabiotic surgery to conjoin mice treated 40 d prior with trans-cervical gp33 peptide as described above (P14 immune hosts) with naive B6 partner mice. We examined each parabiont for the presence of OT-I CD8 + T cells in blood and FRT 35 d after surgery. *P < 0.05, **P < 0.01, Kruskal-Wallis ANOVA (a) or Mann-Whitney U-test (b,d,e). Box plots indicate medians (center lines), 25th and 75th percentiles (bottom and top box edges, respectively), minima and maxima (whiskers), and individual data points (circles). Data are representative of three separate experiments with 4 mice per group per experiment (a-c) or two separate experiments with four parabiont pairs per experiment (d,e).
generation of OT-I memory CD8
+ T cells in both the FRT and the skin (Supplementary Fig. 6 ). Thirty days after VSV-OVA infection, we established parabiotic pairs, each consisting of one mouse that had received transferred CD45.1 + OT-I T cells and one that had received CD90.1 + OT-I T cells, and allowed equilibration of circulating OT-I CD8 + T cells for 14-30 d. We then rechallenged each conjoined parabiont locally with modified VV Ankara expressing the immunodominant SIINFEKL epitope derived from OVA (MVA-OVA) via either the trans-cervical (Fig. 7a-c) or the epicutaneous route 27 ( Fig. 7d-f) . One month later, we used QIM to examine the expansion and origin of OT-I CD8 + T cell populations in each mouse's FRT or skin. There were approximately ninefold more host-derived OT-I CD8 + T cells than parabiotic-partner-derived OT-I CD8 + T cells in both FRT (Fig. 7b) and skin (Fig. 7e) , which indicated that local FRT or skin challenge with MVA-OVA resulted in local amplification of host-derived T RM cell populations. These data suggest that T RM cells may autonomously amplify local immune surveillance and memory in various barrier sites in response to a range of stimuli.
Discussion
This study demonstrates that CD8 + T RM cells within the stroma of the FRT exhibit motility rates that are similar to those of circulating lymphocytes in LNs. In response to local re-encounter with cognate antigen, T RM cells pause, then proliferate even in the absence of CD4 + T cell help. In the contexts examined here, FRT and skin T RM cells dominated the local recall response and made a greater contribution than did circulating memory T cell subsets, including T CM cells, to the expansion of a long-lived anamnestic T RM cell population. These data highlight nonlymphoid-tissue-autonomous amplification of adaptive immune responses.
We observed that T RM cells patrolled with a speed of 10 μ m min -1 within the FRT myometrium, similar to the motility rate observed in SLOs. Unlike uterine myometrium and SLOs, the epidermis is densely populated with stationary keratinocytes, which suggests that motility may be partly regulated by tissue architecture 28, 29 . Indeed, we found that motility was substantially reduced (~6 μ m min -1 ) in the matrix-dense region of the uterine perimetrium. These observations argue against the concept that T RM cells are necessarily stationary within tissues and reveal the marked heterogeneity of T RM cell immunosurveillance patterns, which has important implications for modeling the requirements for immunity at frontline tissues.
It has been reported that after HSV infection in mice, effector CD4 + T cells are required to migrate to the FRT before CD8 + T cells can enter 23 . This important observation, if generalized, suggests that cytotoxic T lymphocyte responses to nonlymphoid tissues are intrinsically delayed, and thus are likely to impede the rapidity of viral control. It is therefore important to note that we observed no impairment in the migration of CD8 Our observations confirmed previous reports that T RM cell reactivation induces the recruitment of bystander (non-antigenspecific) memory T cells to sites of ongoing infection 21, 31, 32 . In the current study, we found that some recruited bystander CD8 + T cells persisted for more than 75 d in the nonlymphoid site of recruitment. This suggests that T cell migration from recirculating to resident compartments could be more dynamic in organisms that experience frequent recall infections (unlike laboratory mice that live in specific-pathogen-free facilities). Antigen encounter in nonlymphoid tissues has a role in shaping T RM cell development, but the rules are unclear and seem to be tissue specific 20, [33] [34] [35] , although this issue has not been well addressed in the FRT. We found that a fraction of recruited bystander memory CD8 + T cells upregulated CD69, but not CD103. Thus, cognate antigen recognition in tissue was clearly not required for CD69 induction. It remains unclear whether bystander recruited T cells, which include T CM cells and T EM cells, had lost the developmental capacity to fully acquire T RM cell differentiation markers, or distribute differently, or whether local infection was required to enhance CD69 and CD103 induction signals 36 . The lineage relationship between T RM cells and other memory T cell subsets is an area of active investigation.
The degree to which T RM cells have the capacity for recall expansion in tissues also remains unclear 8 . Although some reports indicate that neither effector nor memory T cells divide within nonlymphoid tissues, an elegant study in the brain parenchyma challenged this view 37 . It showed that effector T cells could complete a division in situ, although those cells were pre-committed to divide (perhaps in the lymphoid tissue) prior to entry into the central nervous system 37 . Naive T cells can be primed in low-shear-flow vascular compartments, including the liver 38 . T cells can also be induced to divide within nonlymphoid tissue 39 by transplantation of the dorsal root ganglia of HSV-infected mice under the kidney capsule of naive mice, which induces viral reactivation. In this scenario, division depends on CD4 + T cells and dendritic cells, which suggests that the rules for tissue division may be context dependent 39 . Here we found that T RM cells in the FRT could be induced to undergo cell division in situ and complete antigen-induced cytokinesis within only 36 h of local stimulation. This was independent of CD4 + T cell help, and was not impeded when 90% of CD11c + cells were depleted. In addition, in situ T RM cell proliferation dominated secondary expansion.
Residence provides a mechanism for regionalizing immunosurveillance by retaining cells in relevant locations, rather than relying on a tissue-restricted recirculation program. Our study extends this paradigm by revealing tissue-autonomous amplification of local memory, and suggests that iterative stimulation at a local site could enrich memory T cell immunosurveillance at very specific sites. One important implication is that these recall responses would remain undetected if analysis were limited to blood. The clinical relevance of local self-amplifying T cell responses may extend beyond infectious disease 40, 41 , perhaps to include T-cell-driven autoimmune and allergic responses 7, 42 .
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-017-0029-3. ) female mice were from The Jackson Laboratory and were maintained in specific-pathogen-free conditions at the University of Minnesota. CD90.1 + P14, CD45.1 + P14 and CD45.1 + OT-I mice were fully backcrossed to C57BL/6 J mice and maintained in our animal colony. We generated P14 and OT-I reporter mice by crossing the mice with C57BL/6-Tg(UBC-GFP)30Scha/J or B6.129(ICR)-Tg(CAG-ECFP)CK6Nagy/J mice. Sample size was chosen on the basis of previous experience. No sample exclusion criteria were applied. No method of randomization was used during group allocation, and investigators were not blinded. All mice used in experiments were 6-14 weeks of age. All mice were used in accordance with the Institutional Animal Care and Use Committees guidelines at the University of Minnesota.
Adoptive transfers and infections. We generated P14 immune chimeras by transferring 5 × Intravascular staining, lymphocyte isolation and phenotyping. We used an intravascular staining method to discriminate cells present in the vasculature from cells in the tissue parenchyma, as described 43 . We injected mice i.v. with biotin/ fluorochrome-conjugated anti-CD8α through the tail vein. Three minutes after the injection, we killed the animals and harvested tissues as described 44 . Isolated mouse cells were surface-stained with antibodies to CD3 (145-2C11), CD45 (30F-11), CD11b (M1/70), CD11c (N418), CD90.1 (OX-7), CD45. In vivo BrdU assay. For studies investigating BrdU incorporation, animals were injected i.p. with 2 mg of BrdU (Sigma-Aldrich) 2 h before they were killed for cell isolation. Intracellular staining of cells for BrdU and Ki67 was done with the BD BrdU flow kit (BD Biosciences) with antibodies to BrdU (Bu20a) and Ki67 (SolA15) according to the manufacturer's guidelines.
Tissue freezing, immunofluorescence and microscopy. Harvested mouse tissues were fixed in 2% paraformaldehyde for 2 h before being treated with 30% sucrose overnight for cryoprotection. The sucrose-treated tissue was embedded in OCT tissue-freezing medium and frozen in an isopentane liquid bath. Frozen blocks were processed, stained, imaged, and enumerated by QIM as described 12 , including staining with antibodies to the following markers: CD8-β (YTS156.7.7; BD Biosciences), CD90.1 (OX-7; BD Biosciences), CD45.1 (A20; Biolegend), E-cadherin (DECMA-1; Abcam), collagen-IV (goat anti-mouse polyclonal; Millipore), collagen-I (rabbit anti-mouse polyclonal; Millipore), Ki67 (TEC3; Dako), and LCMV nucleoprotein (VL-4; Bioxcell). We also counterstained with 4′ ,6-diamidino-2-phenylindole dihydrochloride (DAPI) to detect nuclei. The following secondary antibodies were from Jackson Immunoresearch: donkey anti-rabbit (polyclonal), bovine anti-goat (polyclonal), and donkey anti-rat (polyclonal).
Preparation of epidermal whole mounts. We prepared epidermal whole mounts for immunofluorescence as described 45 . We prepared epidermal sheets from back skin by affixing the epidermis side to slides with an optically clear doublesided adhesive (Thorlabs). Slides were incubated in 2.5 mg/ml Dispase II (Roche Diagnostics) in PBS for 1 h at 37 °C, and then the dermis was physically removed. Epidermal mounts were fixed in chilled acetone for 5 min. They were subsequently stained, and images were captured as described above. Antigen-specific CD8 + T cells in epidermis were counted manually in Photoshop. The area of the epidermis was measured with the ruler tool in Photoshop.
In vivo antibody treatment and local T RM cell reactivation. We depleted circulating CD90.1 +
CD8
+ P14 T cells by injecting 0.6-1.5 μ g of titrated anti-CD90.1 (HIS51) i.p. as described 16 . To block the migration of peripheral memory CD8
+ T cells to the site of reactivation, we injected 500 µ g of blocking anti-VCAM-1 (M/K-2.7) or anti-CD49d (PS/2) (BioXcell) i.p. 24 h before and 24 h after trans-cervical peptide challenge as described 16 . For local FRT T RM cell rechallenge experiments involving peptides, 50 µ g of the indicated peptides (New England Peptides) was delivered trans-cervically as described 21 in a volume of 30 µ l delivered by modified gel loading pipet. For reactivation of skin T RM cells, 3 × 10 6 PFU of modified vaccinia virus Ankara expressing the SIINFEKL peptide of ovalbumin (MVA-OVA) was delivered epicutaneously into the back skin by 10-15 pokes with a bifurcated needle as described 27 . Reactivation of OT-I T RM cells in FRT was achieved by trans-cervical delivery of either 4 × 10 6 PFU of VV-OVA or 3 × 10 6 PFU of MVA-OVA as indicated.
Parabiotic surgery. Parabiotic surgery was done as described 21 with the following modification. Lateral skin incisions on both pairs were conjoined with surgical wound clips. Parabionts were then allowed to rest for 14-30 d before experiments. Equilibration was confirmed in the peripheral blood before T RM cell reactivation. Two-photon microscopy and analysis. Mice were anesthetized with 2,2,2-tribromoethanol (Avertin), and uterine horns were located through a midline incision along the linea alba. One uterine horn was gently exteriorized and positioned on a custom-made polystyrene platform, where it was stabilized with cyanoacrylate tissue adhesive. The platform allowed constant bathing of the organ in warm oxygenated buffer and permitted continuous temperature monitoring. The mouse was then transferred onto a microscope stage fully enclosed within an environmental chamber that helped maintain body temperature at 36.5 ± 1 °C. Mice were injected with 50 μ l of rhodamine isothiocyanate, 70 K d (20 mg/ml stock), where indicated to visualize blood vessels.
Movies were acquired with an MP SP5 two-photon microscope TCS (Leica) equipped with Mai Tai HP DeepSee lasers (SpectraPhysics), an 8,000-Hz resonant scanner, a 25 × /0.95-NA (numerical aperture) objective, and two NDD and two HyD photomultiplier tubes. Samples were excited at 860 or 890 nm, and multiple fluorophores were imaged with the custom dichroic mirrors with the following collections: SHG, < 440 nm; CFP, 435-485 nm; GFP, 500-520 nm; YFP, 520-550 nm; and rhodamine dextran, 565-605 nm. All imaging studies focused on the perimetrium and myometrium regions of the uterus. Imaging data were processed with Imaris software (versions 7.6.4 and 8.0.1). For the calculation in Fig. 1g , a surface was created for SHG signal and then converted to a distance transformation channel to determine spot distance to the SHG surface at all time points. Determination of mean track velocities (in micrometers per minute) and motility coefficients and other migrational analyses were carried out with MotilityLab (http://www.motilitylab.net/) or a macro 46 . The drift correct function in Imaris and MotilityLab was used to correct for uterine tissue contractions during imaging. In cases where uterine tissue contractions were severe, we injected terbutaline hemisulfate (Sigma-Aldrich), a β -adrenergic agonist, i.p. at 50 mg/kg body weight to achieve transient uterine muscle relaxation. No adverse effect on CD8 + T cell surveillance behavior was noted during this short-term terbutaline treatment.
Bone marrow chimeras and diphtheria toxin treatment. Bone marrow was harvested from femurs and tibias of CD11c-DTR mice, and 1-2 × 10 6 bone marrow cells were injected i.v. into recipient mice that had received a lethal irradiation dose of 1,100 cGy. Mice received antibiotics in drinking water for 4 weeks after irradiation and were allowed 8 weeks for full reconstitution of bone marrow, which was confirmed by analysis of donor peripheral cells. We depleted CD11c
+ cells in the chimeric mice by treating them with an initial dose of 1 μ g of DT i.p. and then 0.2 μ g of DT i.p. every 2 d until the end of the experiment.
Statistics. If the samples followed a Gaussian distribution, then parametric tests (unpaired two-tailed Student's t-test for two groups and one-way ANOVA with Tukey's multiple comparison test for more than two groups) were used. If the samples deviated from a Gaussian distribution, non-parametric tests (MannWhitney U-test for two groups, Kruskal-Wallis with Dunn's multiple comparison test for more than two groups) were used unless otherwise stated. The D' Agostino and Pearson omnibus normality test was used to determine whether samples adhered to a Gaussian distribution. Variances between groups were compared by F test and found to be equal. All statistical analysis was done in GraphPad Prism (GraphPad Software Inc.). P < 0.05 was considered significant. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. Sample size was determined based on previous studies. 3 to 10 mice/group/ timepoint was sufficient to detect differences between groups with power value 0.8 and a 5% significance level in most of the experiments.
Data exclusions
Describe any data exclusions. No data were excluded from the analysis
Replication
Describe whether the experimental findings were reliably reproduced.
All of data were successfully reproduced by each attempt.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomization was done during group allocation. Animals of similar age and sex (liitermates where possible) were used to control for covariates.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Investigators were not blinded.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance. .SJL-PtprcaPepcb/BoyJ (CD45.1) female mice were purchased from The Jackson Laboratory and were maintained in specific pathogen free conditions at the University of Minnesota. CD90.1+ P14, CD45.1+ P14 and CD45.1+ OT-I mice were fully backcrossed to C57BL/6J mice and maintained in our animal colony. P14 and OT-I reporter mice were generated by crossing the mice with ubiquitin-GFP or actin-ECFP mice. Sample size was chosen based on previous experience. No sample exclusion criteria were applied. No method of randomization was used during group allocation and investigators were not blinded. All mice were used in experiments within 6 to 14 weeks of age. All mice were used in accordance with the Institutional Animal Care and Use Committees guidelines at the University of Minnesota.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
This study did not involve human research participants.
